AKT1 and liver cancer: This PKI-587/radiation combined treatment inhibits PI3K/AKT/mTOR and homologous recombination (HR) repair-related kinases such as the ATM and the ATM and Rad3-related (ATR) in liver cancer cells (Table 2) [164].